Posted: 26 Jun 2013 02:00 PM PDT
Results
of a Phase III clinical trial showed that a simple drug regimen of two
anti-clotting drugs - clopidogrel and aspirin - lowered the risk of
stroke by almost one-third, compared to the standard therapy of aspirin
alone, when given to patients who had minor or transient stroke symptoms
to prevent subsequent attacks.
No comments:
Post a Comment